Cell Cycle Disturbances in Schizophrenia: The Journey So Far by Hans-Gert Bernstein et al.
Acta Clin Croat,  Vol. 49,  (Suppl) No. 2,  2010 33
H. G. Bernstein et al. Cell cycle disturbances in schizophrenia
WORKSHOP: CELL CYCLE ABNORMALITIES IN 
SCHIZOPHRENIA
CELL CYCLE DISTURBANCES IN SCHIZOPHRENIA:
THE JOURNEY SO FAR
Hans-Gert Bernstein, Esther Stürze, Bernhard Bogerts
Department of Psychiatry, University of Magdeburg
Department of Psychiatry, University of Magdeburg Leipziger 
Str. 44, D-39120 Magdeburg, Germany
Abstract
As an introduction to the Pula Workshop „Schizo-
phrenia and Cell Cycle Disturbances“, we give a short 
survey on the current knowledge about the impact of 
cell cycle disturbances in schizophrenia. While the ex-
istence of reduced adult neurogenesis in schizophrenia 
is supported by various studies, less is known about 
such disturbances in non-neural cells (for example, in 
oligodendrocytes). We herein try to show that both 
impaired neuronal and oligodendroglial cell cycles 
might contribute to the pathophysiology of schizo-
phrenia, and that  antipsychotic treatment might be a 
way to „normalize“ cell cycle abnormalities.
Schizophrenia is a chronic and disabling mental 
illness aﬀ ecting several millions of people worldwide. 
Th e etiopathogenesis of the disease, however, remains 
enigmatic, and various competing hypotheses have 
been proposed to explain its origin. Amongst these, 
the proposition that schizophrenia may have its roots 
in early brain development has gained much attention. 
During the past decade the scientiﬁ c community has 
witnessed a considerable progress in the understand-
ing of  normal neural development and neurogenesis, 
and convincing evidence has accumulated in favour 
of  abberant neurodeveloment in schizophrenia1. Th is 
neurodevelopmental theory, however, leaves some 
vital questions unanswered. For example, how can a 
purely neurodevelopmental disorder manifest for the 
ﬁ rst time in an adolescent or an adult2? It soon became 
clear that certain „disease-shaping“ pathomechanisms 
must still be active in the adult human brain, which 
contribute to the development and/or progression of 
the disease. So far, mainly neurodegenerative and im-
mune processes have been blamed to be responsible 
for this3.
Why do we assume that cell cycle disturbances may be of 
relevance for  schizophrenia?
Th e discovery of neurogenesis in the postnatal brain 
has added a new, intruiging aspect to the discussion 
about the origin of schizophrenia. It is now beyond 
any doubt that in circumscribed brains areas, particu-
larly in the dentate gyrus and the subventricular zone, 
functional neurons are generated throughout the en-
tire lifespan4. Th is phenomenon has been termed adult 
neurogenesis. Although the actual physiological role 
of this process remains largely unknown, ist function-
ing is obviously necessary to maintain normal brain 
function. Hence, disturbancees of adult neurogenen-
sis (or, more precisely, neural stem cell proliferation) 
might signiﬁ cantly contribute to neuropsychiatric 
disorders, including schizophrenia. Indeed, numerous 
animal studies and investigations in humans give now 
reason to suppose that decreased, and not increased5, 
hippocampal cell proliferation may be part of the 
pathophysiology of schizophrenia. Th is reduced birth 
of new neurons may contribute to to disease-related 
smaller hippocampal volumes, considerable cognitive 
deﬁ cits as well as to delusions and hallucinations6.
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How is the cell cycle controlled, and do the controlling 
agents show abnormal levels in schizophrenia?
Little is currently known about cell cycle regulat-
ing proteins in the adult hippocampus and other brain 
areas. In all mammalian cells including neural stem 
cells, cellular proliferation is mainly controlled during 
the G1 phase of the cell cycle. Cyclins are cell cycle 
proteins known to be positive regulators of the cell 
cycle. Th e cyclins D and E are present in the adult 
subgranular zone and hippocampus7. Both cyclins D1 
and D2 have been found upregulated in schizophre-
nia (8, 9). Interestingly, cyclin D2 was identiﬁ ed as a 
part of the regulatory network of glutamic acid decar-
boxylase (GAD67), an enzyme which is profoundly 
dysregulated in schizophrenia8.
Cyclin-dependent kinases, which control the cell 
cycle by negatively regulating cell cycle progression, 
which are. expressed in proliferating neural stem cells, 
are reduced in their expression in schizophrenia8,10. 
In addition, intracerebroventricular infusion of a 
non-selective cyclin-dependent kinase inhibitors de-
creases cell proliferation in the subgranular zone in 
rats11. Furthermore, the suppression of the expression 
of the gene Disrupted-in-Schizophrenia 1 (DISC 1) 
was shown to strongly reduce neural progenitor pro-
liferation, leading to premature cell cycle exit and dif-
ferentiation. DISC1 mediates this function by regu-
lating glycogen synthase kinase-3 beta12. Th is might 
be of considerable importance for our understanding 
of schizophrenia, since DISC1 has repeatedly been 
linked with the disease. Lastly, adult neurogenesis is 
under control of neurotrophic factors, most of which 
are known to be altered in their expression in schizo-
phrenia13.
Does antipsychotic treatment „normalize“ the cell cycle 
disturbances  in schizophrenia?
Initially, reduced neurogenesis was detected in 
postmortem hippocampi of neuroleptic- treated, 
chronic schizophrenics6,14, So, the spontaneous an-
swer to this question would be a clear „No“. In sup-
port of this failure,  results from animal studies could 
be taken that show unchanged levels of stem cell 
proliferation after haloperidol treatment. One study, 
however, demonstrated an increase in adult neurogen-
esis upon treatment. In two studies it was found that 
chronic treatment with the atypical antipsychotic clo-
zapine does not inﬂ uence proliferation or survival of 
newborn cells in the hippocampal dentat gyrus, while 
acute adminstration doubled the number of BrdU-
incorporating cells. Results with olanzapine are also 
contradictory (reviewed in ref. 6). Our group could 
show that repeated application of subanesthetic doses 
of the noncompetitive N-methyl-D-aspartate receptor 
antagonist ketamine, which has been shown to mimic 
model aspects of schizophrenia in animals, stimulates 
the hippocampal neurogenesis15, and that both halo-
peridol and risperidone promote stem cell survival in 
rats (16, and this symposium). Th us, further research 
is needed in order to get more conclusive answers as 
to whether or not antipsychotic treatment is helpful 
in „normalizing“ cell cycle in schizophrenia (see also 
below).
Abnormal cell cycles and schizophrenia – is it all with the 
neurons?
Th e fascination of adult neurogenesis and ist pos-
sible disturbances in schizophrenia should not allow 
us to obscure our view of non-neural types in the 
brain, namely oligodendroglial cells. Schizophrenia is 
increasingly conceptualised as an illness of disturbed 
functional circuitry, and a wide range of white mat-
ter abnormalities have been revealed in schizophre-
nia. Th ese include volume reductions, hypodensities, 
myelination defects, and especially alterations of den-
sity, morphology and gene expression proﬁ les of the 
myelin-forming cells, oligodendrocytes and their pro-
genitors (for recent review see ref. 17).
Th ere are numerous reports about reduced oligo-
dendrocyte density in schizophrenia, which may re-
sult from impaired mitoses of these cells. However, 
there is yet only circumstantial evidence in favour of 
disease-related oligodendrocyte cycle abnormalities 
in schizophrenia. In a recent, comprehensive analy-
sis Katsel and colleagues9 found that eight cell-cycle 
related antigens (including cyclins D1 and D2) are 
upregulated, and nine other antigens (indluding cy-
clin-dependent kinase inhibitors) are down-regulated 
in OLs isolated from postmortem brains of schizo-
phrenics. Remarkably, the expression diﬀ erences 
were more pronounced in anti-psychotic medication 
free patients with schizophrenia than in treated ones. 
Th e authors conclude that the normal patterns of 
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cell cycle gen and protein expression is disrupted in 
schizophrenia, and that this disruption may signiﬁ -
cantly contribute to oligodendroglial deﬁ cits observed 
in schizophrenia. In this study,  a near-signiﬁ cant 
change was observed for prohibitin, a mitochondrial 
protein which is prominently involved in cell cycle 
control18. Th e number of prohibitin expressing neu-
rons19 and oligodendrocytes (this symposium) is in-
creased  in schizophrenia. It should be emphasized, 
however, that prohibitin is expressed in immature and 
mature (postmitotic) OLs . Th us, a possible inﬂ uence 
of prohibitin on the cell cycle is by far not the only 
function of this multi-talented protein, which may be 
compromised in schizophrenia..
In sum, it becomes obvious that cell cycle distur-
bances are possibly not restricted to neurons, but might 
be a general phenomenon in schizophrenia20, which 
deserves much more attention in future research.
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